What You Should Know: - ObvioHealth and Mi-Helper, Inc. announce a partnership to conduct a decentralized clinical trial for a non-invasive neuromodulation device for the treatment of migraines. The randomized controlled trial will be fully remote, enabling data capture from home—where the device is intended to be used. - Mi-Helper has been developed to meet a massive unmet need for effective, targeted, and drug-free pain management of migraines, a condition which impacts 1 billion
Read More
ObvioHealth
ObvioHealth Launches Digital Therapeutics API for Clinical Trials
What You Should Know: - ObvioHealth launches proprietary application programming interface (API) tailored specifically for digital therapeutics (DTx) clinical trials. - ObvioHealth’s API ensures tight integration between the digital therapeutic and the ObvioGo platform, providing sponsors with accurate data to correlate efficacy with adherence to the DTx. In addition, ObvioGo’s integration reduces participant task duplication because—in most cases—outcomes can be passively captured
Read More
ObvioHealth & Oracle Collaborate to Seamlessly Integrate Diverse Data Sets Into Decentralized Clinical Trials in APAC
What You Should Know: - Today, ObvioHealth and Oracle have announced a partnership to enable the rapid collection, integration and analysis of this complex data to get breakthrough therapies to market faster and cheaper within the APAC region. This partnership will integrate ObvioGo, ObvioHealth’s next generation decentralized clinical trial (DCT) platform and mobile app, and Oracle Clinical One Cloud Service, facilitating pharma-grade analytics and reporting that can
Read More
ObvioHealth, RedHill Biopharma Launches First in Kind Remote COVID-19 Therapy Trial
What You Should Know: - RedHill Biopharma, a specialty biopharmaceutical company, and ObvioHealth, a global virtual research organization, have partnered on the largest remote clinical study for a new at-home COVID-19 treatment, Upamostat. - The trial is being performed completely remotely in patients’ homes using ObvioHealth’s clinical trial ecosystem including digital devices, a patient-centric smartphone application and home healthcare visits. - The randomized, double-blind,
Read More
COVID-19 Patient Registry Launches to Monitor Symptomatic and Asymptomatic COVID-19 Patients
What You Should Know: - Recruitment for the first comprehensive COVID-19 national patient registry opens today for symptomatic and asymptomatic patients in the six-months following diagnosis. - Patient data will be collected remotely for a clinical study using a blood test and a new mobile app, Obvio-19 from ObvioHealth. ObvioHealth, a digital research company, announces the launch of a COVID-19 patient registry named Obvio-19 to monitor COVID-19 prevalence, symptoms and immune
Read More
ObvioHealth Launches Mobile App to Transform Clinical Studies
Clinical trials are a crucial component to advancing healthcare, bringing new therapies to market and better understanding the pathological process of disease in the human body. That said, the clinical research industry is bogged down in antiquated processes, and is hungry for innovative tech that puts patients first to drive the industry forward.ObvioHealth, a healthcare technology company, just announced the official launch of its mobile application for site-less clinical studies—ClaimIt. The
Read More
